Prognostic significance of SERPINE2 in gastric cancer and its biological function in SGC7901 cells

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 5, 2015, Pages 805-812

  Wang, Kun ^a   Wang, Bin ^a   Xing, Ai Yan ^a,b   Xu, Ke Sen ^b   Li, Guang Xin ^a   Yu, Zhen Hai ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Gastric cancer; Growth; Invasion; Migration; Prognosis; SERPINE2; Tumor aggressiveness

Indexed keywords

AGAR; MESSENGER RNA; SMALL INTERFERING RNA; TETRAZOLIUM; PROTEASE NEXIN I; SERPINE2 PROTEIN, HUMAN;

ADULT; AGED; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GASTRIC CANCER CELL LINE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SERPINE2 GENE; STOMACH CANCER; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; STOMACH TUMOR; TUMOR CELL LINE;

ADULT; AGED; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RNA, SMALL INTERFERING; SERPIN E2; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84928264169     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1858-1     Document Type: Article

References (17)

1. Bergeron S, Lemieux E, Durand V, Cagnol S, Carrier JC, Lussier JG, Boucher MJ, Rivard N (2010) The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis. Mol Cancer 9:271
2. Buchholz M, Biebl A, Neesse A, Wagner M, Iwamura T, Leder G, Adler G, Gress TM (2003) SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo. Cancer Res 63:4945–4951
3. Candia BJ, Hines WC, Heaphy CM, Griffith JK, Orlando RA (2006) Protease nexin-1 expression is altered in human breast cancer. Cancer Cell Int 6:16
4. DeMeo D, Mariani T, Lange C, Lake S, Litonjua A, Celedon J, Reilly J, Chapman HA, Sparrow D, Spira A et al (2006) The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Proc Am Thorac Soc 3:502
5. Dorn J, Beaufort N, Schmitt M, Diamandis EP, Goettig P, Magdolen V (2014) Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers. Crit Rev Clin Lab Sci 51:63–84
6. Fayard B, Bianchi F, Dey J, Moreno E, Djaffer S, Hynes NE, Monard D (2009) The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. Cancer Res 69:5690–5698
7. Gao S, Krogdahl A, Sorensen JA, Kousted TM, Dabelsteen E, Andreasen PA (2008) Overexpression of protease nexin-1 mRNA and protein in oral squamous cell carcinomas. Oral Oncol 44:309–313
8. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
9. Kukkonen MK, Tiili E, Hämäläinen S, Vehmas T, Oksa P, Piirilä P, Hirvonen A (2011) SERPINE2 haplotype as a risk factor for panlobular type of emphysema. BMC Med Genet 12:157
10. Li G, Hu Y, Huo Y, Liu M, Freeman D, Gao J, Liu X, Wu DC, Wu H (2006) PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin. J Biol Chem 281:10663–10668
11. McKee CM, Xu D, Cao Y, Kabraji S, Allen D, Kersemans V, Beech J, Smart S, Hamdy F, Ishkanian A et al (2012) Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma. J Clin Investig 122:4025–4036
12. McKee CM, Xu D, Muschel RJ (2013) Protease nexin 1: a novel regulator of prostate cancer cell growth and neo-angiogenesis. Oncotarget 4:1–2
13. Nagahara A, Nakayama M, Oka D, Tsuchiya M, Kawashima A, Mukai M, Nakai Y, Takayama H, Nishimura K, Jo Y et al (2010) SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer. Biochem Biophys Res Commun 391:1641–1646
14. Neesse A, Wagner M, Ellenrieder V, Bachem M, Gress TM, Buchholz M (2007) Pancreatic stellate cells potentiate proinvasive effects of SERPINE2 expression in pancreatic cancer xenograft tumors. Pancreatology 7:380–385
15. Selzer-Plon J, Bornholdt J, Friis S, Bisgaard HC, Lothe IM, Tveit KM, Kure EH, Vogel U, Vogel LK (2009) Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis. BMC Cancer 9:201
16. Wieczorek E, Wasowicz W, Gromadzinska J, Reszka E (2014) Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: A mini-review. Int J Urol. doi:10.1111/iju.12431
17. Xu D, McKee CM, Cao Y, Ding Y, Kessler BM, Muschel RJ (2010) Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1. Cancer Res 70:6988–6998